New Healthcare research report from Euromonitor International is now available from Fast Market Research
Boston, MA -- (SBWIRE) -- 10/29/2014 -- In January 2013, the Medicines Evaluation Board fixed the maximum pack size of acetaminophen 500mg to 50 units in chemists/pharmacies and no more than 20 units in other retail channels. This decision came as studies showed that acetaminophen intake had been involved in several suicide cases. The MEB also recommends that pharmacists and other retailers better inform consumers about the risks and offer free help and advice. This decision could help raise awareness about a drug that is often considered as harmless by the general public. However, several organisations such as the CBD (Central Board of Pharmacists) voiced their concern about this policy which does little to limit consumption as consumers can easily buy from different retail channels.
Bayer Consumer Care BV maintained its leading position in analgesics with a 22% value share in 2013 thanks to its key brands Finimal and Aleve, as well as a range of smaller brands. Both Finimal and Aleve are well established among consumers and widely distributed in retail. Aleve posted a slight increase in value share in 2013, while Finimal's share stagnated due to its higher unit price.
View Full Report Details and Table of Contents
Analgesics will record a slight decline in value, with sales set to fall by 2% over the forecast period as a whole at constant 2013 prices. Demand will remain relatively steady in volume terms and there is expected to be little opportunity to add more value to the category. Population growth will keep a low pace, while the median age of the population will rise. This will have an impact on paediatric analgesics, which is set to see value sales rise at a 1% CAGR at constant 2013 prices over the forecast period, reflecting a marginal slowdown compared to the review period. However, there will be some room for growth in the category as the level of penetration is lower than adult analgesics.
Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Netherlands with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Analgesics industry in Netherlands, our research will save you time and money while empowering you to make informed, profitable decisions.
The Analgesics in Netherlands market research report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volumes and values, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent market research methodology, conducted in-country
Our market research reports answer questions such as:
- What is the market size of Analgesics in Netherlands?
- What are the major brands in Netherlands?
- Are combination products with acetaminophen still popular?
Reasons to Get this Report
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Healthcare research reports at Fast Market Research
You may also be interested in these related reports:
- Analgesics in Japan
- Analgesics in Portugal
- Analgesics in Romania
- Analgesics in Switzerland
- Analgesics in Saudi Arabia
- Analgesics in the Czech Republic
- Analgesics in New Zealand
- Analgesics in Germany
- Analgesics in Israel
- Analgesics in Indonesia